[Form 3] MiniMed Group, Inc. Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
MiniMed Group, Inc. director Glenn A. Eisenberg filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as a reporting insider of the company. The filing does not list any equity transactions or existing derivative positions.
Positive
- None.
Negative
- None.
FAQ
What does MiniMed Group (MMED) disclose in Glenn A. Eisenberg's Form 3?
The Form 3 shows that Glenn A. Eisenberg is a director and now a reporting insider of MiniMed Group, Inc. It is an initial beneficial ownership statement and does not report any stock purchases, sales, or derivative positions.
Does the MMED Form 3 for Glenn A. Eisenberg report any stock transactions?
No, the Form 3 for Glenn A. Eisenberg reports no stock transactions. All transaction counts and share amounts in the summary are zero, indicating no reported purchases, sales, exercises, gifts, or restructurings at the time of this filing.
What is the purpose of Glenn A. Eisenberg's Form 3 for MiniMed Group (MMED)?
The Form 3 serves as Glenn A. Eisenberg’s initial beneficial ownership report as a director of MiniMed Group, Inc. It formally records his insider reporting status with the SEC, even though no holdings or transactions are detailed in this filing.
Does the MMED Form 3 include any derivative securities for Glenn A. Eisenberg?
No, the Form 3 lists no derivative securities for Glenn A. Eisenberg. The derivative summary is empty and the derivative transaction count is zero, indicating no options, warrants, or similar instruments reported in this initial ownership statement.
Are there any notable footnotes in Glenn A. Eisenberg's MMED Form 3 filing?
The Form 3 includes an empty footnote entry, with no specific explanations or disclaimers provided. There are no references to voting or investment authority limitations, related entities, or Rule 10b5-1 trading plans in the available data.